Report : Asia Pacific Preoperative Infection Prevention and Wound Cleansing Device Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Preoperative Infection Prevention Devices and Preoperative Wound Cleansing Devices), Surgery (Cataract Surgery, Cesarean Surgery, Gastric Bypass, Appendectomy, Colectomy And Colostomy, Esophagectomy, Biopsy, Cholecystectomy, Mastectomy, Cosmetic Surgery, and Others), and Application (Preoperative Hair Removal, Preoperative Skin Preparation, Intraoperative Wound Irrigation Solution, and Others)
At 6.9% CAGR, the Asia Pacific Preoperative Infection Prevention & Wound Cleansing Device Market is speculated to be worth US$ 661.15 million by 2028, says Business Market Insights
According to Business Market Insights’ research, the Asia Pacific preoperative infection prevention & wound cleansing device market was valued at US$ 414.49 million in 2021 and is expected to reach US$ 661.15 million by 2028, registering a CAGR of 6.9% from 2021 to 2028. R&D and product developments and guidelines for infection prevention and control are the critical factors attributed to the Asia Pacific preoperative infection prevention & wound cleansing device market expansion.
Prevention of SSIs requires surveillance activities that can lead to effective mitigation strategies. SSI prevention is a complex process and requires integrating various measures before, during, and after surgery. International guidelines are unavailable, and inconsistencies in the interpretation of evidence and recommendations of national guidelines have been identified. Owing to the burden of SSIs across the world, numerous gaps in evidence-based guidance, and the need for standardization and a regional approach. The Asia Pacific Society of Infection Control (APSIC) published the APSIC Guidelines for preventing surgical site infections (SSIs) in 2018. It aims to highlight practical recommendations in a concise format to assist healthcare facilities in achieving high standards of preoperative, perioperative, and postoperative procedures. According to the Australian Commission on Safety and Quality in Healthcare, Australia reports over 165,000 healthcare-associated severe infections in hospitals each year. Nosocomial infections are the most common complication in hospital patients. In China, the Ministry of Health required hospitals to set up a hospital-acquired infection (HAI) management committee. Hospitals are required to survey the prevalence of HAIs at least once a year and employ at least one specialist per 200–250 beds. They are also needed to conduct antimicrobial drug surveillance and surveillance involving patients and medical staff for HAIs across the hospital. HAIs data is a part of the annual reports submitted by hospitals to the National Health Insurance Fund under the Ministry of Health. Still, there is no standardized and structured reporting methodology. Owing to the rise in the formulation of guidelines for infection control across the world, the preoperative infection prevention and wound cleaning devices market is expected to witness lucrative growth opportunities during the forecast period.
On the contrary, high costs and reimbursement of advanced devices hurdles the growth of Asia Pacific preoperative infection prevention & wound cleansing device market.
Based on product, the Asia Pacific preoperative infection prevention & wound cleansing device market is bifurcated into preoperative infection prevention devices and preoperative wound cleansing devices. The preoperative infection prevention devices segment held 69.8% share of Asia Pacific preoperative infection prevention & wound cleansing device market in 2021, amassing US$ 289.51 million. It is projected to garner US$ 465.22 million by 2028 to expand at 7.0% CAGR during 2021–2028. The preoperative infection prevention devices segment is further subsegmented into infection prevention supplies, medical waste disposable devices, and infection prevention equipments.
Based on surgery, the Asia Pacific preoperative infection prevention & wound cleansing device market is segmented into cataract surgery, cesarean surgery, gastric bypass, appendectomy, colectomy and colostomy, esophagectomy, biopsy, cholecystectomy, mastectomy, cosmetic surgery, and others. The cosmetic surgery segment held 21.9% share of Asia Pacific preoperative infection prevention & wound cleansing device market in 2021, amassing US$ 90.85 million. It is projected to garner US$ 148.16 million by 2028 to expand at 7.2% CAGR during 2021–2028.
Based on application, the Asia Pacific preoperative infection prevention & wound cleansing device market is segmented into preoperative hair removal, preoperative skin preparation, intraoperative wound irrigation solution, and others. The preoperative hair removal segment held 43.2% share of Asia Pacific preoperative infection prevention & wound cleansing device market in 2021, amassing US$ 179.11 million. It is projected to garner US$ 288.19 million by 2028 to expand at 7.0% CAGR during 2021–2028. The preoperative hair removal segment is further subsegmented into clippers, razors, and depilators. The preoperative skin preparation segment is further subsegmented into single use and multiple use. The intraoperative wound irrigation solution segment is further subsegmented into detergents, antibiotic laden lavage, antiseptic agents, and sterile normal saline market.
Based on country, the Asia Pacific preoperative infection prevention & wound cleansing device market has been categorized into Australia, China, India, Japan, South Korea, and the Rest of Asia Pacific. Our regional analysis states that China captured 40.5% share of Asia Pacific preoperative infection prevention & wound cleansing device market in 2021. It was assessed at US$ 168.03 million in 2021 and is likely to hit US$ 270.22 million by 2028, exhibiting a CAGR of 7.0% during the forecast period.
Key players profiles in the Asia Pacific preoperative infection prevention & wound cleansing device market report are 3M Co; Bactiguard AB; Becton Dickinson and Co; bioMerieux SA; Cardinal Health Inc; Dynarex Corp; Getinge AB; Medline Industries Inc; and Steris Plc, among others.
Contact Us
Contact Person: Sameer Joshi
Phone: +1- 646- 491- 9876
Email id: sam@businessmarketinsights.com